PLA2R-positive membranous nephropathy treated with rituximab (MENTOR regimen) in a patient with concomitant endometrial carcinoma: A case report. REV SEN [Internet]. 2026 Jul. 23 [cited 2026 Jul. 23];14(3S):57-8. Available from: https://www.rev-sen.ec/index.php/revista/article/view/197